Clinical Trial Update: Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating topical Lactobacillus reuteri for androgenetic alopecia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Androgenetic Alopecia (AGA) | Phase 2 | Status: RECRUITING